Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Patent
1994-11-23
2000-03-14
Budens, Robert D.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
424 854, 4241581, 53038823, 5303892, A61K 39395, C07K 1624
Patent
active
060369566
ABSTRACT:
The present invention is directed to immunotherapeutic methos for treating systemic lupus erythematosus (SLE) by administerring polyclonal or monoclonal antibodies specific for gamma interferon (IFN-gamma).
REFERENCES:
patent: 4362155 (1982-12-01), Skurkovich
patent: 4514507 (1985-04-01), Secher
patent: 4599306 (1986-07-01), Altrock
patent: 4666865 (1987-05-01), Chang et al.
patent: 4883784 (1989-11-01), Kaneko
patent: 4885290 (1989-12-01), Asano et al.
patent: 4897264 (1990-01-01), Novick et al.
patent: 4908387 (1990-03-01), Levine et al.
patent: 4920097 (1990-04-01), Gottlieb et al.
patent: 5556754 (1996-09-01), Singer et al.
patent: 5571499 (1996-11-01), Hafler et al.
patent: 5571500 (1996-11-01), Hafler et al.
patent: 5607675 (1997-03-01), Strom
patent: 5695785 (1997-12-01), Ofosu-Appiah
Acha-Orbea et al. "T Cell Receptors in Murine Autoimmune Diseases" (1989) Ann. Rev. Immunol. 7:371-405.
Billiau, A. "Gamma-interferon: the match that lights the fire?" (1988) Immunol Today 9(2):37-40.
Braude et al. "In Vitro Suppression of Anti-DNA Antibody and Immunoglobulin Syntheses in Systemic Lupus Erythematosus Patients by Human Gamma Interferon" (1988) J. Rheumatol. 15(3):438-444.
Cooper et al. "Suppression of Murine Collagen-induced Arthritis with Monoclonal Anti-Ia Antibodies and Augmentation with IFN-.gamma." (1988) J. Immunol. 141:1958-1962.
Dijkmans et al. "Interferon .gamma. : a master key in the immune system" (1988) Curr. Opin. Immunol. 1:269-274.
Funauchi et al. "Mixed Lymphocyte Reaction in Interferon-.gamma. Treated (NZB.times. NZW)F.sub.1 Mice" (1989) Toh. J. Exp. Med. 158:155-161.
Heremans et al. "Interferon treatment of NZB Mice: Accelerated Progression of autoimmune Disease" (1978) Infect. Immun. 21(3):925-930.
Klippel et al. "New Therapies for the Rheumatic Diseases" (1989) Bullet. Rheumatic. Dis 38(4):1/8.
Mackay et al. "Premises for immune interventional therapy in rheumatoid arthritis" (1988) Postgrad. Med. J. 64:522-530.
Minoda et al. "Effect of Interferon-.gamma. on the Abnormality of T Cell Activation in NZB Mice" Clin. Immunopath. (1988) 49:283-291.
Minoda et al. "Examination of the inhibitory effects of interferon-.gamma. on interleukin-4-induced stimulation of resting B cells from NZB/NZW F1 mice" (1989) Clin. Exp. Immunol. 78:115-119.
Schattner, A. "Screeing of herpes simples virus during pregnancy" (1988) Brit. Med. J. 290.
Skurkovich et al. "A Disturbance of Interferon Synthesis with the Hyperpduction of Unusual Kinds of Interferon can Trigger Autoimmune Disease and Play a Pathogenetic Role in AIDS: The Removal of These Interferons can be Therapeutic" (1993) Med. Hypoth. 41:177-185.
Skurkovich et al. "A Disturbance of Interferon Synthesis with the Hyperpduction of Unusual Kinds of Interferon can Trigger Autoimmune Disease and Play a Pathogenetic Role in AIDS: The Removal of These Interferons can be Therapeutic" (1994) Med. Hypoth. 42:27-35.
Strigard, K. "Experimental allergic neuritis; studies on pathogenesis and immunoregulation" (1989) Acta Neurol. Scand. 123(80):7-29.
Adelman et al., "Treatment of (NZB .times. NZW)F.sub.1 Disease with Anti-I-A Monoclonal Antibodies" J. Exp. Med. (1983) 158: 1350-1355.
Andrews et al., "Spontaneous Murine Lupus-Like Syndromes" J. Exp. Med. (1978) 148: 1198-1215.
Bessis et al., "Anti-inflammatory cytokines as treatment of inflammtion in models of autoimmune diseases" C.R. Seances Soc. Biol. Fil. (1995) 189: 579-590.
Boissier et al., "Biphasic effect of interferon-.gamma. in murine collagen-induced arthritis" Eur. J. Immunol. (1995) 25: 1184-1190.
Knight and Adams, "Three Genes for Lupus Nephritis in NZB .times. NZW Mice" J. Exp. Med. (1978) 147: 1653-1660.
Kuby, J., "Autoimmunity" Immunology (1994) Chapter 19, Second Edition, W.H. Freeman and Company, New York, pp. 451-452.
Primi et al. , "Genetic Control of Lymphocyte Suppression" J. Immunology (1978) 121: 2241-2243.
Tang et al., "The effects of a monoclonal antibody to interferon-.gamma. on experimental autoimmune thyroiditis (EAT): prevention of disease and decrease of EAT-specific T cells" Eur. J. Immunol. (1993) 23: 275-278.
Theofilopoulos et al., "Murine Models of Systemic Lupus Erythematosus" Adv. Immun. (1985) 37: 269-390.
Abbas et al., Cellular and Molecular Immunology, Wonsiewicz, ed. (1991), pp. 319-331 and pp. 354-376.
McEvoy and Thomas (1990) in Autoimmunity and the Pathogenesis of Diabetes (Ginsberg-Fellner and McEvoy eds.) Springer-Verlag, New York, pp. 165-183.
Oi, V.T. et al., "Immunoglobulin gene expression in transformed lymphoid cells" Proc. Natl. Acad. Sci. USA (1983) 80:825-829.
Campbell et al., "IFN-.gamma. Induces Islet Cell MHC Antigens and Enhances Autoimmune, Streptozotocin-Induced Diabetes in the Mouse", J. Immunol., 140:1111-1116 (1988).
Debray-Sachs et al., "Prevention of Diabetes in NOD Mice Treated with Antibody to Murine IFN.gamma.", J. Autoimm., 4:237-248 (1991).
Watanabe and Jacob, "Regulation of MHC Class II Antigen Expression", J. Immunol., 146:899-905 (1991).
Jacob et al., "Monoclonal Anti-Tumor Necrosis Factor Antibody Renders Non-Obese Diabetic Mice Hypersensitive to Irradiation and Enhances Insulitis Development", Intl. Immunol., 4:611-614 (1992).
Jacob and McDevitt, Interferon-.gamma. and TNF Autoimmune Disease Models, pp. 107-126 (1991).
Isaacs et al., "Humanised monoclonal antibody therapy for rheumatoid arthritis" The Lancet (1992) 340:748-752.
Bacha et al., "Anti-arthritic effects demonstrated by an interleukin-2 receptor-targeted cytotoxin (DAB.sub.486 IL-2) in rat adjuvant arthritis" Eur. J. Immunol. (1992) 22:1673-1679.
News Release Summary dated May 3, 1993, Seragen, Inc..
Smith et al., (1983) Ann. Rev. Immunol. 1:175-210.
McDevitt, (1986) Clinical Research 34(2):163-175.
Bottazzo et al., (1983) Lancet, p. 1115-1119.
Hooks et al., (1980) Annals New York Academy of Sciences, p. 21-32.
Hooks et al., (1979) New England Journal of Medicine 301(1):5-8.
Iwatani et al., (1986) Journal of Clinical Endocrinology and Metabolism 63(3):695-708.
Marx, (1988) Science 242:863-865.
Lafferty et al., (1983) Ann. Rev. Immunol. 1:143-173.
Mason et al., (1986) Ann. Rev. Immunol. 4:119-145.
Regulation of Immune Gene Expression, Edited by Marc Feldman and Andrew McMichael (Humana Press, NJ) , p. 258-271.
Dijkema et al, (1985) EMBO Journal 4:761-767.
Van Der Meide et al., (1986) J. Gen. Virol. 67:1059-1071.
Schwartz, R.S., "Autoimmunity and Autoimmune Diseases," in Fundamental Immunology, 3.sup.rd Ed., Paul, W.E., Ed., Raven Press, Ltd., New York, 1993, pp. 1033, 1069-1074.
Brostoff et al., "SLE and Other Connective Tissue Disorders," in Clinical Immunology, Brostoff et al., Eds., Gower Medical Publishing, New York, 1991, p. 6.1-6.14.
Patterman et al, "Murine Models of Spontaneous Systemic Lupus Erythematosus," in Autoimmune Disease Models: A Guidebook, Cohen et al., Eds., Academic Press, San Diego, 1994, p. 217-243.
Nicoletti et al., "In Vivo Treatment With A Monoclonal Antibody to Interferon Gamma Neither Affects The Survival Nor The Incidence of Lupus-Nephritis In The MRL/pr-/pr Mouse," Immunopharmacology 24:11-16, 1992.
Jacob et al., "In Vivo Treatment of (NZB .times. NZW)F1 Lupuslike Nephritis With Monoclonal Antibody to .gamma. Interferon," J. Exp. Med. 166:798-803, Sep. 1987.
Golbus et al., "Increased Immunoglobulin Response to .gamma.-Interferon By Lymphocytes From Patients With Systemic Lupus Erythematosus," Clin. Immunology Immunopath. 46:129-140, 1988.
Braude et al., "In Vitro Suppression Of Anti-DNA Antibody and Immunoglobulin Synthesis In Systemic Lupus Erythematosus Patients By Human Gamma Interferon," J. Rheumatol. 15(3):438-444, Mar. 1988.
Jacob et al., "Tumor Necrosis Factor Alpha In Murine Systemic Lupus Erythematosus Disease Models: Implications For Genetic Predisposition And Immune Regulation," Cytokine 3(6):551-561, Nov. 1991.
Ozmen et al., "Experimental Therapy of Systemic Lupus Erythematosus: The Treatment of NZB/w Mice With Soluble Interferon-.gamma. Receptor Inhibits The Onset of Glomeralo nephritis," Eur. J. Immunol. 25:6-12, 1995.
Ozmen et al., "Soluble Interferon-.gamma. Receptor: A Therapeutically Useful Drug For Sys
Holoshitz Joseph H.
Jacob Chaim O.
McDevitt Hugh O.
van der Meide Peter
Budens Robert D.
The Leland Stanford Junior University
LandOfFree
Method and dosage form using an antagonist to gamma interferon t does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and dosage form using an antagonist to gamma interferon t, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and dosage form using an antagonist to gamma interferon t will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-166456